The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Ergotamine in the acute treatment of migraine: A review and European consensus
Abstract
Ergotamine has been used in clinical practice for the acute treatment of migraine for over 50 years, but there has been little agreement on its place in clinical practice. An expert group from Europe reviewed the pre-clinical and clinical data on ergotamine as it relates to the treatment of migraine. From this review, specific suggestions for the patient groups and appropriate use of ergotamine have been agreed. In essence, ergotamine, from a medical perspective, is the drug of choice in a limited number of migraine sufferers who have infrequent or long duration headaches and are likely to comply with dosing restrictions. For most migraine sufferers requiring a specific anti-migraine treatment, a triptan is generally a better option from both an efficacy and side-effect perspective.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Goodman & Gilman's The Pharmacological Basis of Therapeutics
Brunton, L. L. (1985) · Cited by 7,321
International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin).
Hoyer, D., Clarke, D. E., Fozard, J. R., Hartig, P. R., Martin, G. R., Mylecharane, E. J., Saxena, P. R., & Humphrey, P. P. (1994) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06783-3 · Cited by 3,003
Brain stem activation in spontaneous human migraine attacks
Weiller, C., May, A., Limmroth, V., Jüptner, M., Kaube, H., Schayck, R. V., Coenen, H. H., & Dlener, H. C. (1995) · Nature Medicine · doi:10.1038/nm0795-658 · Cited by 1,384
Goadsby, P. J., & Edvinsson, L. (1993) · Annals of Neurology · doi:10.1002/ana.410330109 · Cited by 1,158
On some physiological actions of ergot
Dale, H. H. (1906) · The Journal of Physiology · doi:10.1113/jphysiol.1906.sp001148 · Cited by 1,011
Guidelines for Controlled Trials of Drugs in Migraine: Second Edition
International Headache Society Clinical Trials Subcommittee, Tfelt-Hansen, P., Block, G., Dahlöf, C., Diener, H.-C., Ferrari, M., Goadsby, P., Guidetti, V, Jones, B., Lipton, R., et al. (2000) · Cephalalgia · doi:10.1046/j.1468-2982.2000.00117.x · Cited by 698
Self-citationFunctional Correlates of Serotonin 5-HT1Recognition Sites
Hoyer, D. (1988) · Journal of Receptor Research · doi:10.3109/10799898809048978 · Cited by 562
Transformation of Episodic Migraine Into Daily Headache: Analysis of Factors
Mathew, N. T., Stubits, E., & Nigam, M. P. (1982) · Headache: The Journal of Head and Face Pain · doi:10.1111/j.1526-4610.1982.hed2202066.x · Cited by 374
Coronary Side-Effect Potential of Current and Prospective Antimigraine Drugs
MaassenVanDenBrink, A., Reekers, M., Bax, W. A., Ferrari, M. D., & Saxena, P. R. (1998) · Circulation · doi:10.1161/01.cir.98.1.25 · Cited by 323
Ergot Alkaloids and Related Compounds
(1978) · Springer eBooks · doi:10.1007/978-3-642-66775-6 · Cited by 320
Adham, N., Kao, H. T., Schecter, L. E., Bard, J., Olsen, M., Urquhart, D., Durkin, M., Hartig, P. R., Weinshank, R. L., & Branchek, T. A. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.2.408 · Cited by 289
Pfaffenrath, V., Cunin, G., Sjonell, G., & Prendergast, S. (1998) · Headache: The Journal of Head and Face Pain · doi:10.1046/j.1526-4610.1998.3803184.x · Cited by 184
A Randomized, Double-Blind Comparison of Sumatriptan and Cafergot in the Acute Treatment of Migraine
(1991) · European Neurology · doi:10.1159/000116759 · Cited by 170
Hoskin, K. L., Kaube, H., & Goadsby, P. J. (1996) · Brain · doi:10.1093/brain/119.1.249 · Cited by 169
A placebo-controlled crossover study of rizatriptan in the treatment of multiple migraine attacks
Kramer, M. S., Matzura‐Wolfe, D., Polis, A., Getson, A. J., Amaraneni, P. G., Solbach, M. P., McHugh, W. B., Feighner, J. P., Silberstein, S., Reines, S. A., et al. (1998) · Neurology · doi:10.1212/wnl.51.3.773 · Cited by 146
Headache after frequent use of serotonin agonists zolmitriptan and naratriptan
Limmroth, V., Kazarawa, Z., Fritsche, G., & Diener, H. (1999) · The Lancet · doi:10.1016/s0140-6736(05)74950-3 · Cited by 131
Peters, G. A., & Horton, B. T. (1951) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(25)10824-0 · Cited by 128
Analgetika-induzierter Dauerkopfschmerz
DICHGANS, J., Diener, H., Gerber, W. D., Verspohl, E. J., Kukiolka, H., & Kluck, M. (2008) · DMW - Deutsche Medizinische Wochenschrift · doi:10.1055/s-2008-1069197 · Cited by 114
Buzzi, M. G., Moskowitz, M. A., Peroutka, S. J., & Byun, B.-J. (1991) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1991.tb09805.x · Cited by 108
Basic Pharmacological Properties
Müller‐Schweinitzer, E., & Weidmann, H. (1978) · Springer eBooks · doi:10.1007/978-3-642-66775-6_3 · Cited by 98
Leysen, J. E., Gommeren, W., Heylen, L. I., Luyten, W. H. M. L., de Weyer, I. V., Vanhoenacker, P. K., Haegeman, G., Schotte, A., Gompel, P. V., Wouters, R., et al. (1996) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09616-6 · Cited by 92
Serotonin 5-HT1B/1D Receptor Agonists in Migraine
Goadsby, P. J. (1998) · CNS Drugs · doi:10.2165/00023210-199810040-00005 · Cited by 87
Acute Migraine Attack Therapy: Comparison of Naproxen Sodium and an Ergotamine Tartrate Compound
Pradalier, A., Rancurel, G., Dordain, G., Verdure, L., Rascol, A., & Dry, J. (1985) · Cephalalgia · doi:10.1046/j.1468-2982.1985.0502107.x · Cited by 70
Villalón, C. M., de Vries, P. W., Rabelo, G., Centurión, D., Sánchez‐López, A., & Saxena, P. R. (1999) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702324 · Cited by 69
Vuori, E., Lönnqvist, J. K., & Klaukka, T. (1994) · BMJ · doi:10.1136/bmj.308.6943.1573a · Cited by 65
Identification of drugs inhibiting thein vitrometabolism of tacrolimus by human liver microsomes
Christians, U., SCHMIDT, G., Bader, A., Lampen, A., Schottmann, R., Linck, A., & Sewing, K. (1996) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1996.tb00181.x · Cited by 64
ERGOTAMINE TOLERANCE IN PATIENTS WITH MIGRAINE
Friedman, A. P., & STORCH, T. J. C. V. (1955) · JAMA · doi:10.1001/jama.1955.02950280005002 · Cited by 55
Pharmacokinetics of ergotamine in healthy volunteers following oral and rectal dosing
Sanders, S. W., Haering, N., Mosberg, H., & Jaeger, H. (1986) · European Journal of Clinical Pharmacology · doi:10.1007/bf00541538 · Cited by 49
Drug points: Severe ergotism associated with interaction between ritonavir and ergotamine
Liaudet, L., Buclin, T., Jaccard, C., & Eckert, P. (1999) · BMJ · doi:10.1136/bmj.318.7186.771 · Cited by 48
Placebo-Controlled Clinical Trials with Ergotamine in the Acute Treatment of Migraine
Dahlöf, C. G. H. (1993) · Cephalalgia · doi:10.1046/j.1468-2982.1993.1303166.x · Cited by 44
Clinical Ergotism With Lingual Ischemia Induced by Clarithromycin-Ergotamine Interaction
Horowitz, R. S., Dart, R. C., & Gomez, H. F. (1996) · Archives of Internal Medicine · doi:10.1001/archinte.1996.00440040134015 · Cited by 32
A Double‐blind Crossover Trial of Isometheptene mucate Compound and Ergotamine in Migraine
Yuill, G. M., Swinburn, W. R., & Liversedge, L. A. (1972) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.1972.tb04381.x · Cited by 29
Clinical Trial of Inhaled Ergotamine Tartrate in Migraine
Crooks, J., Stephen, S., & Brass, W. (1964) · BMJ · doi:10.1136/bmj.1.5377.221 · Cited by 25
Chapter 8 Receptors for 5-hydroxytryptamine
Bobker, D. H., & Williams, J. T. (1993) · New comprehensive biochemistry · doi:10.1016/s0167-7306(08)60361-0 · Cited by 10
Heeringa, M. J., Zweers, P. G. M. A., A, D. M. R., de Groot, H., 刘正印, & 王爱霞 (2001) · doi:10.3760/cma.j.issn.1007-9742.2001.01.116 · Cited by 6
Cited by
Migraine — Current Understanding and Treatment
Goadsby, P. J., Lipton, R. B., & Ferrari, M. D. (2002) · New England Journal of Medicine · doi:10.1056/nejmra010917 · Cited by 1,918
Ferrari, M. D., Roon, K. I., Lipton, R. B., & Goadsby, P. J. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06711-3 · Cited by 987
EFNS guideline on the drug treatment of migraine—revised report of an EFNS task force
Evers, S., Áfra, J., Frese, A., Goadsby, P. J., Linde, M., May, A., & Sándor, P. S. (2009) · European Journal of Neurology · doi:10.1111/j.1468-1331.2009.02748.x · Cited by 892
Migraine: epidemiology and systems of care
Ashina, M., Katsarava, Z., Do, T. P., Buse, D. C., Pozo-Rosich, P., Özge, A., Krymchantowski, A. V., Lebedeva, E. R., Ravishankar, K., Yu, S., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(20)32160-7 · Cited by 833
Guidelines for Controlled Trials of Drugs in Migraine: Second Edition
International Headache Society Clinical Trials Subcommittee, Tfelt-Hansen, P., Block, G., Dahlöf, C., Diener, H.-C., Ferrari, M., Goadsby, P., Guidetti, V, Jones, B., Lipton, R., et al. (2000) · Cephalalgia · doi:10.1046/j.1468-2982.2000.00117.x · Cited by 698
Self-citation
Metadata
- Authors
- Tfelt-Hansen, P.
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2000-01-01
- Volume
- 123
- Issue
- 1
- Pages
- 9-18
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- OpenAlex
- W2147688165
- Cited by
- 393
- References
- 35
- FWCI
- 14.48
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.